| Literature DB >> 32711508 |
Leandro F M Rezende1, Eliana Murata1, Beatriz Giannichi1, Luciana Yuki Tomita1, Gabriela Arantes Wagner1, Zila M Sanchez1, Carlos Celis-Morales2,3,4, Gerson Ferrari5.
Abstract
BACKGROUND: To identify modifiable risk factors that contribute to cancer holds important public health relevance for setting up prevention strategies. Therefore, the aim of this study was to estimate the proportion of cancer cases and deaths attributable to alcohol consumption, high body mass index (BMI), low fruits and vegetables consumption, lack of physical activity, tobacco smoking, and passive smoking in Chile in 2018.Entities:
Keywords: Cancer; Chile; Epidemiology; Lifestyle
Year: 2020 PMID: 32711508 PMCID: PMC7382839 DOI: 10.1186/s12885-020-07187-4
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Distribution (proportion or mean and 95% confidence intervals) of lifestyle risk factors associated with cancer incidence and mortality in Chile
| Exposure and distribution and theoretical minimum risk exposure level (in italic) | Men | Women | Cancer sites-related (ICD-10) |
|---|---|---|---|
| 20.5 (18.7–22.5) | 44.1 (42.2–45.7) | Lip, oral cavity, pharynx (C00-C14); Esophagus (C15; squamous cell carcinoma only); Colorectum (C18-C20); Liver (C22); Gallbladder (C23); Pancreas (C25); Larynx (C32); female Breast (C50) | |
| Light (1–12.5 g/day) | 31.5 (29.3–33.6) | 41.4 (39.8–43.2) | |
| Moderate (12.6–49.9 g/day) | 39.1 (37.0–41.5) | 13.8 (12.6–14.8) | |
| Heavy (≥50 g/day) | 8.8 (7.6–10.2) | 0.7 (0.4–1.0) | |
| Mean and standard deviation ( | 28.42 (28.20–28.65) | 29.62 (29.43–29.83) | Esophagus (C15; adenocarcinoma only); Stomach (C16.0; cardia only); Colorectum (C18-C20); Liver (C22); Gallbladder (C23); Pancreas (C25); female Breast (C50; postmenopausal cancers only); Corpus uteri (C54-C55); Ovary (C56); Kidney, renal pelvis (C64-C66); Thyroid (C73); Multiple myeloma (C90). Prostate (C61; advanced only) |
| 11.6 (10.3–12.9) | 14.7 (13.6–15.9) | Oral cavity/pharynx (C00-C14); Larynx (C32) | |
| 300–399 g/day | 9.1 (7.9–10.4) | 11.9 (10.9–13.0) | |
| 200–299 g/day | 18.1 (16.4–19.8) | 19.8 (18.5–21.1) | |
| 100–199 g/day | 38.0 (35.9–40.2) | 36.9 (35.4–38.4) | |
| 0–99 g/day | 23.2 (21.5–25.9) | 16.6 (15.4–17.8) | |
| 6.2 (5.2–7.2) | 6.5 (5.7–7.3) | Lung, bronchus. Trachea (C33-C34) | |
| 200–249 g/day | 6.1 (5.1–7.2) | 7.9 (7.1–8.8) | |
| 150–199 g/day | 11.2 (9.9–12.7) | 15.4 (14.3–16.5) | |
| 100–149 g/day | 7.7 (6.5–8.9) | 6.1 (5.4–6.9) | |
| 50–99 g/day | 27.5 (25.6–29.4) | 30.5 (29.0–32.0) | |
| 0–49 g/day | 41.2 (39.1–43.5) | 33.6 (32.1–35.1) | |
| 0.6 (0.3–0.9) | 0.2 (0.1–0.4) | Colon (C18); female Breast (C50; post-menopausal cancers only) | |
| 4000–7999 MET-min/week | 5.1 (4.1–6.1) | 1.8 (1.4–2.2) | |
| 600–3999 MET-min/week | 23.6 (21.9–25.4) | 13.7 (12.6–14.8) | |
| < 600 MET-min/week | 70.7 (68.8–72.7) | 84.3 (83.1–85.5) | |
| 82.7 (81.0–84.3) | 87.0 (85.9–88.1) | Lung, bronchus, trachea (C33-C34) | |
| yes | 17.3 (15.7–19.0) | 13.0 (11.9–14.1) | |
| 37.7 (35.6–39.8) | 52.6 (51.0–54.1) | Oral cavity/pharynx (C00-C14); Esophagus (C15); Stomach (C16); Colorectum (C18-C20); Liver (C22); Pancreas (C25); Nasal cavity/paranasal sinus (C30-C31); Larynx (C32); Lung, bronchus, trachea (C33-C34); Cervix (C53); Kidney, renal pelvis, ureter(C64-C66); Urinary bladder (C67); Myeloid leukemia (C92) | |
| Former | 28.9 (27.0–30.9) | 21.6 (20.4–22.9) | |
| Current | 33.4 (31–3-35.4) | 25.8 (24.4–27.1) | |
Fig. 1Proportion and number of all cancer cases attributable to lifestyle risk factors in Chile in 2018, by exposure and sex.
Proportion and number of cancer cases attributable to lifestyle risk factors in Chile in 2018 by exposure, sex, and cancer site
| Men | Women | Both | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Exposure/cancer site | Total number of cases | PAF (%) | Attributable cases | Total number of cases | PAF (%) | Attributable cases | Total number of cases | PAF (%) | Attributable cases |
| Lung | 2163 | 90.7 | 1963 | 1708 | 87.3 | 1492 | 3871 | 89.2 | 3454 |
| Larynx | 225 | 85.7 | 193 | 28 | 82.2 | 23 | 253 | 85.3 | 216 |
| Oral cavity/pharynx | 299 | 63.9 | 191 | 219 | 59.1 | 129 | 518 | 61.9 | 321 |
| Esophagus | 412 | 58.9 | 243 | 372 | 56.8 | 211 | 784 | 57.9 | 454 |
| Bladder | 964 | 57.9 | 558 | 382 | 50.7 | 194 | 1346 | 55.8 | 752 |
| Liver | 866 | 36.7 | 317 | 709 | 18.6 | 132 | 1575 | 28.5 | 449 |
| Stomach | 3429 | 30.8 | 1056 | 1733 | 16.8 | 291 | 5162 | 26.1 | 1348 |
| Cervix | – | – | – | 1546 | 25.4 | 392 | 1546 | 25.4 | 392 |
| Kidney | 1215 | 29.2 | 354 | 705 | 8.7 | 61 | 1920 | 21.6 | 415 |
| Pancreas | 794 | 16.7 | 133 | 841 | 21.6 | 182 | 1635 | 19.2 | 314 |
| Myeloid leukemia | 522 | 29.4 | 153 | 514 | 4.5 | 23 | 1036 | 17.1 | 177 |
| Colorectum | 2952 | 16.1 | 474 | 2821 | 16.5 | 466 | 5773 | 16.3 | 940 |
| Corpus uteri | – | – | – | 933 | 44.8 | 418 | 933 | 44.8 | 418 |
| Kidney | 1215 | 26.7 | 324 | 705 | 29.4 | 207 | 1920 | 27.7 | 531 |
| Gallbladder | 851 | 22.1 | 188 | 1848 | 26.8 | 496 | 2699 | 25.3 | 683 |
| Liver | 866 | 20.5 | 177 | 709 | 23.2 | 165 | 1575 | 21.7 | 342 |
| Colorectum | 2952 | 16.7 | 492 | 2821 | 10.8 | 304 | 5773 | 13.8 | 796 |
| Pancreas | 794 | 13.4 | 107 | 841 | 12.1 | 102 | 1635 | 12.7 | 208 |
| Breast | – | – | – | 5391 | 11.2 | 603 | 5391 | 11.2 | 603 |
| Multiple myeloma | 434 | 11.5 | 50 | 389 | 8.7 | 34 | 823 | 10.2 | 84 |
| Thyroid | 173 | 17.1 | 29 | 875 | 6.3 | 55 | 1048 | 8.1 | 85 |
| Ovary | – | – | – | 826 | 7.5 | 62 | 826 | 7.5 | 62 |
| Stomach | 3429 | 7.1 | 242 | 1733 | 5.5 | 95 | 5162 | 6.5 | 338 |
| Esophagus | 412 | 6.5 | 27 | 372 | 6.1 | 23 | 784 | 6.3 | 50 |
| Prostate | 6574 | 3.0 | 195 | 6574 | 3.0 | 195 | |||
| Oral cavity/pharynx | 299 | 44.6 | 133 | 219 | 11.1 | 24 | 518 | 30.5 | 158 |
| Esophagus | 412 | 39.7 | 163 | 372 | 16.8 | 63 | 784 | 28.8 | 226 |
| Larynx | 225 | 25.9 | 58 | 28 | 7.9 | 2 | 253 | 23.9 | 61 |
| Gallbladder | 851 | 15.3 | 130 | 1848 | 5.8 | 107 | 2699 | 8.8 | 237 |
| Liver | 866 | 8.4 | 73 | 709 | 5.1 | 36 | 1575 | 6.9 | 109 |
| Colorectum | 2952 | 12.1 | 356 | 2821 | 1.1 | 32 | 5773 | 6.7 | 388 |
| Breast | – | – | – | 5391 | 4.2 | 229 | 5391 | 4.2 | 229 |
| Pancreas | 794 | 4.2 | 34 | 841 | 0.7 | 6 | 1635 | 2.4 | 39 |
| Colorectum | 2952 | 11.4 | 336 | 2821 | 15.2 | 428 | 5773 | 13.2 | 764 |
| Breast | – | – | – | 5391 | 9.6 | 520 | 5391 | 9.6 | 520 |
| Larynx | 225 | 25.2 | 57 | 28 | 23.2 | 7 | 253 | 25.0 | 63 |
| Oral cavity/pharynx | 299 | 25.2 | 75 | 219 | 23.2 | 51 | 518 | 24.4 | 126 |
| Lung | 2163 | 14.3 | 310 | 1708 | 13.6 | 232 | 3871 | 14.0 | 542 |
| Lung | 2163 | 2.2 | 48 | 1708 | 1.6 | 27 | 3871 | 1.9 | 75 |
PAF population attributable fraction
Fig. 2Proportion and number of cancer cases attributable to lifestyle risk factors in Chile in 2018, by cancer site and sex.
Fig. 3Proportion and number of total cancer deaths attributable to lifestyle risk factors in Chile in 2018, by exposure and sex
Fig. 4Proportion and number of cancer deaths attributable to lifestyle risk factors in Chile in 2018, by cancer site and sex
Proportion and number of cancer deaths attributable to lifestyle risk factors in Chile in 2018, by exposure, sex, and cancer site
| Men | Women | Both | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Exposure/cancer site | Total number of deaths | PAF (%) | Attributable deaths | Total number of deaths | PAF (%) | Attributable deaths | Total number of deaths | PAF (%) | Attributable deaths |
| Lung | 2055 | 90.7 | 1865 | 1525 | 87.3 | 1332 | 3580 | 89.3 | 3197 |
| Larynx | 148 | 85.7 | 127 | 23 | 82.2 | 19 | 171 | 85.2 | 146 |
| Oral cavity/pharynx | 140 | 63.9 | 89 | 66 | 59.1 | 39 | 206 | 62.4 | 129 |
| Esophagus | 362 | 58.9 | 213 | 306 | 56.8 | 174 | 668 | 57.9 | 387 |
| Bladder | 417 | 57.9 | 241 | 201 | 50.7 | 102 | 618 | 55.5 | 343 |
| Liver | 778 | 36.7 | 285 | 666 | 18.6 | 124 | 1444 | 28.3 | 409 |
| Stomach | 2342 | 30.8 | 721 | 1136 | 16.8 | 191 | 3478 | 26.2 | 912 |
| Cervix | – | – | – | 725 | 25.4 | 184 | 725 | 25.4 | 184 |
| Kidney | 636 | 29.2 | 185 | 342 | 8.7 | 30 | 978 | 22.0 | 215 |
| Pancreas | 763 | 16.7 | 127 | 816 | 21.6 | 176 | 1579 | 19.2 | 304 |
| Myeloid leukemia | 406 | 29.4 | 119 | 402 | 4.5 | 18 | 808 | 17.0 | 138 |
| Colorectum | 1538 | 16.1 | 247 | 1562 | 16.5 | 258 | 3100 | 16.3 | 505 |
| Corpus uteri | – | – | – | 295 | 44.8 | 132 | 295 | 44.8 | 132 |
| Kidney | 636 | 26.7 | 170 | 342 | 29.4 | 100 | 978 | 27.6 | 270 |
| Gallbladder | 560 | 22.1 | 124 | 1063 | 26.8 | 285 | 1623 | 25.2 | 409 |
| Liver | 778 | 20.5 | 159 | 666 | 23.2 | 155 | 1444 | 21.7 | 314 |
| Colorectum | 1538 | 17.8 | 274 | 1562 | 11.2 | 175 | 3100 | 14.5 | 449 |
| Breast | – | – | – | 1688 | 13.0 | 220 | 1688 | 13.0 | 220 |
| Pancreas | 763 | 13.4 | 102 | 816 | 12.1 | 99 | 1579 | 12.7 | 201 |
| Multiple myeloma | 328 | 11.5 | 38 | 284 | 8.7 | 25 | 612 | 10.2 | 63 |
| Thyroid | 49 | 17.1 | 8 | 106 | 6.3 | 7 | 155 | 9.7 | 15 |
| Prostate | 2270 | 8.6 | 195 | 2270 | 8.6 | 195 | |||
| Ovary | – | – | – | 469 | 7.5 | 35 | 469 | 7.5 | 35 |
| Stomach | 2342 | 7.1 | 165 | 1136 | 5.5 | 63 | 3478 | 6.6 | 228 |
| Esophagus | 362 | 6.5 | 23 | 306 | 6.1 | 19 | 668 | 6.3 | 42 |
| Oral cavity/pharynx | 140 | 44.6 | 62 | 66 | 11.1 | 7 | 206 | 33.9 | 70 |
| Esophagus | 362 | 39.7 | 144 | 306 | 16.8 | 51 | 668 | 29.2 | 195 |
| Larynx | 148 | 25.9 | 38 | 23 | 7.9 | 2 | 171 | 23.5 | 40 |
| Gallbladder | 560 | 15.3 | 86 | 1063 | 5.8 | 61 | 1623 | 9.1 | 147 |
| Liver | 778 | 8.4 | 65 | 666 | 5.1 | 34 | 1444 | 6.9 | 99 |
| Colorectum | 1538 | 12.1 | 186 | 1562 | 1.1 | 18 | 3100 | 6.6 | 203 |
| Breast | – | – | – | 1688 | 4.2 | 72 | 1688 | 4.2 | 72 |
| Pancreas | 763 | 4.2 | 32 | 816 | 0.7 | 5 | 1579 | 2.4 | 38 |
| Colorectum | 1538 | 13.6 | 210 | 1562 | 16.7 | 261 | 3100 | 15.2 | 470 |
| Breast | – | – | – | 1688 | 11.2 | 190 | 1688 | 11.2 | 190 |
| Larynx | 148 | 25.2 | 37 | 23 | 23.2 | 5 | 171 | 25.0 | 43 |
| Oral cavity/pharynx | 140 | 25.2 | 35 | 66 | 23.2 | 15 | 206 | 24.6 | 51 |
| Lung | 2055 | 14.3 | 294 | 1525 | 13.6 | 207 | 3580 | 14.0 | 501 |
| Lung | 2055 | 2.2 | 46 | 1525 | 1.6 | 24 | 3580 | 2.0 | 70 |
PAF population attributable fraction